ICMR has submitted a proposal to the Modi govt recommending the cancer drug developed by AstraZeneca, which apparently improved clinical outcomes of patients with severe Covid-19.
ICMR did not look for presence of neutralising antibodies, which fight off infection, as tests to detect their presence were unavailable when the study was launched in April.
The drug was tested on 40 patients during phase 2 trials. But, the govt’s expert panel found the sample size ‘inadequate’ to approve the drug for marketing in India.
Lancet notes the patient tested negative twice between the two positive tests & also highlights significant genetic variation in the two strains of the novel coronavirus.
Experimental antibody cocktail Trump was given has generated a row, partly because it uses embryonic stem cell research that has stirred the US president’s voter base in past.
The study says ‘there was no clinical benefit’ of HCQ as ‘pre-exposure prophylaxis’. India continues to use it among healthcare and frontline workers as a prophylactic drug.
Whether it is due to the alleged unofficial ban on The Bengal Files or allegations by Gopal Mukherjee’s family against Agnihotri, everyone in the state wants to know more about Mukherjee.
As devastated farmers begin to come to terms with the fallout, 4 lakh hectares of land under paddy cultivation across state is flooded. Punjab is among the biggest contributors to PDS.
New Delhi: Army chief General Upendra Dwivedi has strongly backed the idea of theaterisation, saying it is inevitable and the need of the hour.
Speaking...
In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?
COMMENTS